Ruth Murphy
Queen's University Belfast(GB)Novartis (Switzerland)(CH)Bristol-Myers Squibb (Germany)(DE)Eli Lilly (United States)(US)Pfizer (United Kingdom)(GB)Leo Pharma (Australia)(AU)Mater Misericordiae University Hospital(IE)Janssen (France)(FR)Samsung (United States)(US)Sheffield Teaching Hospitals NHS Foundation Trust(GB)Galderma (France)(FR)Boehringer Ingelheim (India)(IN)Sheffield Children's NHS Foundation Trust(GB)Almirall (Spain)(ES)NIHR Manchester Biomedical Research Centre(GB)University of Sheffield(GB)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Autoimmune Bullous Skin Diseases, Oral Health Pathology and Treatment, Autoimmune and Inflammatory Disorders Research
Most-Cited Works
- → British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017(2017)263 cited
- → Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse(2003)249 cited
- → Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council(2019)233 cited
- → British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update(2020)221 cited
- → European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and Venereology(2020)179 cited
- → HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis(2018)169 cited